Clinical Trial Update: Stocrin Re-examination Study (0831-028)

View source ↗

Summary

Clinical Trial Update for Stocrin Re-examination Study (0831-028) focusing on HIV infection. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Stocrin (efavirenz)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: HIV Infection | Status: COMPLETED